GWPH - GW Pharmaceuticals EPS beats by $0.02 beats on revenue November, 03 2020 07:32 AM GW Pharmaceuticals Plc GW Pharmaceuticals (GWPH): Q3 GAAP EPS of -$0.03 beats by $0.02.Revenue of $137.05M (+50.7% Y/Y) beats by $11.08M.Shares +0.8% PM.Press Release For further details see: GW Pharmaceuticals EPS beats by $0.02, beats on revenue